Comparing the current results to its competitors, Avinger Inc reported Revenue increase in the 3 quarter 2024 by 2.74 % year on year. The sales growth was above Avinger Inc 's competitors' average revenue growth of 0.4 %, achieved in the same quarter.
Avinger Inc 's Comment on Competition and Industry Peers
The company operates in the medical device industry for peripheral artery disease (PAD) treatment, a competitive and rapidly evolving sector influenced by new product introductions, clinical research, reimbursement policies, and corporate combinations. Its products compete with various devices, including chronic total occlusion (CTO) crossing devices, stents, balloons, atherectomy catheters, and vascular surgery products. Major competitors in the CTO crossing, stent, and balloon segments include Abbott Laboratories, AngioDynamics, Becton Dickinson, Boston Scientific, Cardinal Health, Cook Medical, Medtronic, and Philips. In the atherectomy market, competitors include AngioDynamics, Boston Scientific, Cardiovascular Systems, Medtronic, and Philips. Some competitors have integrated intravascular imaging with atherectomy devices, and others may develop onboard visualization technologies. Additionally, pharmaceutical companies producing drugs for PAD symptoms and companies supplying surgical products for peripheral and coronary procedures also compete in this market.
With modest revenue growth of 2.74 % within Overall company, Avinger Inc managed to improve its market share within this segment to approximately 0 %. << More on AVGR Market Share.
*Market share is calculated based on total revenue.
Bioxytran Inc's business model revolves around developing and commercializing innovative therapeutic solutions, specifically focusing on oxygen therapeutics for various medical applications.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Angiodynamics Inc is a medical technology company that focuses on the development and commercialization of devices and treatments for minimally invasive procedures. Their business model centers around the manufacturing and sale of innovative medical devices such as catheters, lasers, and fluid systems used in the diagnosis and treatment of various vascular conditions. They primarily generate revenue through the sale of these products to healthcare providers and hospitals worldwide.
Sources:
Avinger Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Avinger Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
